Cost-benefit analysis in U.S. regulatory decision-making

What does the future hold?

The Society for Benefit-Cost Analysis¹ recently shared a blog titled: On Balance: Will U.S. Regulatory Benefit-Cost Analysis Survive? by: Lisa A. Robinson, Harvard T.H. Chan School of Public Health

I was particularly taken with the author’s description of CBA as a “voyage of discovery” - a view I strongly share:

Textbooks describe the goal of benefit-cost…